Delivers clinically-validated digital therapeutics to help seriously ill patients manage the burden of illness on their own devices.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to helping patients live better. Blue Note is merging deep scientific and clinical expertise with digital and gaming innovation to transform care for seriously ill patients. Working closely with leading medical researchers and patient advocacy organizations, Blue Note is creating clinically-validated, FDA-approvable prescription-only digital devices to treat the burden of illness. Their team aims to make therapy available to any patient, at any time, on patients’ own mobile devices.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Blue Note Therapeutics Management Team
Investors
Alumni Ventures Group
Fenway Summer LLC
JAZZ Venture Partners
Memorial Sloan Kettering Cancer Center (MSK)
Summer VC
Blue Note Therapeutics Valuations & Financials
View real-time NPM data on Blue Note Therapeutics stock including daily Blue Note Therapeutics stock price estimates, valuation history, and historical share price information. Access Blue Note Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Blue Note Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Blue Note Therapeutics? Get in touch to learn more.
Similar Companies
like Blue Note Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Unstructured
Enterprise Software
Convert messy files that prepare content for AI use by structuring, embedding, and enriching unstructured data for modeling and analytics.
MarketerHire
Provides an on-demand marketing talent marketplace and workforce management platform.
Checkmate
Commerce & Marketplaces
Applies tailored discount codes based on your online activity to simplify and optimize your shopping.
Catawiki
Online auction marketplace specializing in curated sales of unique and rare collectible items through weekly expert-led auctions.
Rakurai
Web3 & Digital Assets
Solana validator optimizing transaction processing speed and efficiency, enhancing block rewards for node operators and stakers.
Brooklyn Dumpling Shop
Distributes innovative fusion dumplings through physical eateries, venue partnerships, and retail grocery channels.
Rael
Consumer
Develops and markets natural menstrual care products and phase-specific skincare solutions to support women's holistic cycle wellness.
BeeKeeperAI
Utilizes zero-trust confidential computing to enable secure collaboration between algorithm developers and sensitive data stewards.
FAQ
We have answers
Blue Note Therapeutics stock does not trade on public stock exchanges. Blue Note Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Blue Note Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Blue Note Therapeutics Stock does not trade on public stock exchanges. In order to sell Blue Note Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Blue Note Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Blue Note Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Blue Note Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Blue Note Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Blue Note Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Blue Note Therapeutics is a private company and has not had an IPO. There is currently no Blue Note Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Blue Note Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
